Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 3;10:980433. doi: 10.3389/fmolb.2023.980433

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Bajo-Santos, Brokāne, Zayakin, Endzeliņš, Soboļevska, Belovs, Jansons, Sperga, Llorente, Radoviča-Spalviņa, Lietuvietis and Linē.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

EV isolation and characterization. (A) Workflow of the study. (B) Western blot of CD63, ALIX, TSG101 and calnexin in LNCaP prostate cancer cells and pre-operation urinary and plasma EVs from three different patients. (C) Representative TEM image of urinary EVs. (D) Representative TEM image of plasma EVs. (E) Paired dot plots showing the numbers of EVs per ml of urine before (PreOp) and after radical prostatectomy (PostOp). (F) Paired dot plots showing the numbers of EVs per ml of plasma before and after radical prostatectomy. Wilcoxon matched-paired signed rank test was used to assess the statistical significance of the differences between groups.